117 related articles for article (PubMed ID: 21649738)
1. Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions.
Frey K; Fiechter M; Schwager K; Belloni B; Barysch MJ; Neri D; Dummer R
Exp Dermatol; 2011 Aug; 20(8):685-8. PubMed ID: 21649738
[TBL] [Abstract][Full Text] [Related]
2. Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma.
Schliemann C; Wiedmer A; Pedretti M; Szczepanowski M; Klapper W; Neri D
Leuk Res; 2009 Dec; 33(12):1718-22. PubMed ID: 19625084
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies.
Pedretti M; Rancic Z; Soltermann A; Herzog BA; Schliemann C; Lachat M; Neri D; Kaufmann PA
Atherosclerosis; 2010 Feb; 208(2):382-9. PubMed ID: 19699478
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer.
Pedretti M; Soltermann A; Arni S; Weder W; Neri D; Hillinger S
Lung Cancer; 2009 Apr; 64(1):28-33. PubMed ID: 18799229
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.
Brack SS; Silacci M; Birchler M; Neri D
Clin Cancer Res; 2006 May; 12(10):3200-8. PubMed ID: 16707621
[TBL] [Abstract][Full Text] [Related]
6. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.
Kääriäinen E; Nummela P; Soikkeli J; Yin M; Lukk M; Jahkola T; Virolainen S; Ora A; Ukkonen E; Saksela O; Hölttä E
J Pathol; 2006 Oct; 210(2):181-91. PubMed ID: 16924594
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
[TBL] [Abstract][Full Text] [Related]
8. A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer.
Schwager K; Villa A; Rösli C; Neri D; Rösli-Khabas M; Moser G
Head Neck Oncol; 2011 May; 3():25. PubMed ID: 21548989
[TBL] [Abstract][Full Text] [Related]
9. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
10. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.
Ambort D; Brellier F; Becker-Pauly C; Stöcker W; Andrejevic-Blant S; Chiquet M; Sterchi EE
Matrix Biol; 2010 Jan; 29(1):31-42. PubMed ID: 19748582
[TBL] [Abstract][Full Text] [Related]
11. Analysis of combinatorial variability reveals selective accumulation of the fibronectin type III domains B and D of tenascin-C in injured brain.
Dobbertin A; Czvitkovich S; Theocharidis U; Garwood J; Andrews MR; Properzi F; Lin R; Fawcett JW; Faissner A
Exp Neurol; 2010 Sep; 225(1):60-73. PubMed ID: 20451518
[TBL] [Abstract][Full Text] [Related]
12. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D
Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
15. Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
Franz M; Brehm BR; Richter P; Gruen K; Neri D; Kosmehl H; Hekmat K; Renner A; Gummert J; Figulla HR; Berndt A
J Mol Histol; 2010 Feb; 41(1):39-50. PubMed ID: 20232238
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
Mårlind J; Kaspar M; Trachsel E; Sommavilla R; Hindle S; Bacci C; Giovannoni L; Neri D
Clin Cancer Res; 2008 Oct; 14(20):6515-24. PubMed ID: 18927291
[TBL] [Abstract][Full Text] [Related]
17. Expression of tenascin-C splice variants by human skin cells.
Latijnhouwers MA; de Jongh GJ; Bergers M; de Rooij MJ; Schalkwijk J
Arch Dermatol Res; 2000 Sep; 292(9):446-54. PubMed ID: 11000288
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C in primary malignant melanoma of the skin.
Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S
Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480
[TBL] [Abstract][Full Text] [Related]
19. Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblasts.
Degen M; Goulet S; Ferralli J; Roth M; Tamm M; Chiquet-Ehrismann R
Clin Exp Allergy; 2009 May; 39(5):688-99. PubMed ID: 19309351
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
Kageshita T; Yoshii A; Kimura T; Kuriya N; Ono T; Tsujisaki M; Imai K; Ferrone S
Cancer Res; 1993 Oct; 53(20):4927-32. PubMed ID: 8104688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
